Hemostemix Inc (2VF0)

Vera told investors to expect three things in Q2: (1) APOLLO update in DLBCL, maximum dose level, (2) FDA feedback on APOLLO study design, potentially a pivotal Phase 2, and (3) initiation of the company-sponsored pancreatic trial.
Do we think he’ll deliver on any of them? A little over 1 wee

Dang under .28 lol..company doing buyback if drops continue?

SPCX, won’t report its quarter until August

Options.
X

A fair question came up about what "a rights offering that incentivizes registered-holder participation" would actually look like in concrete terms, and whether it makes sense for a company at this price. Worth answering plainly, because there's a real mechanism here and also a couple of mischaracte

Mark Smith at the JP Morgan summit. “Blah, blah, blah, imminent…..blah, blah, blah, Stellantis….,blah, blah, blah, EXIM……blah, blah, blah, binding agreement soon……blah, blah, blah, final feasibility in a couple weeks……blah, blah, blah

In closing, Mark Smith never fails to disappoint &

HEHEHE, I got all your backs in here ;)

INOD(95.50)-Anyone follow this GenAI data engineering company? Been in a nice upswing this month,after a great Q1 report last month. Don't see any specific reason for today's drop on a green market day(news of a new CFO seems inconsequential as he is only replacing an interim CFO). Maybe just profit

NO SHORT FOR S&P I WAS WRONG eom

good morning Harley!!!

Thanks Wizard. Could you post the same link for the Russell 1000.

I'm buying the fear & this dip was bruuuutal, expect the big $$$ to push back imo

I don't think anyone expected this much shorting, since there was so much volume not that long ago. But someone is doing all they can to keep XERI's PPS as low as possible. Not clear what their But they can only keep a lid on it for so long. It's only a matter of time before the buyers start to real

Loyal Companies https://share.google/gJKQOp3xoNqWpUFVD

There's a photo of Chad McKay on this website to compare with..

They have a contact form but it only ask for the name, subject and message. Doesn't ask for an email of phone #.

Aptar Releases 2025 Corporate Sustainability ReportJune 18, 2026 5:00 PM
Business WireAptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today released its

Another Tie2xVEGF bispecific for AMD/DME:

https://www.globenewswire.com/news-release/2026/06/18/3314508/0/en/memento-medicines-launches-with-93-million-series-a-financing-to-advance-tie2-agonist-and-vegf-inhibitor-bispecific-antibody-therapy-for-retinal-diseases.html

Epsium Enterprise Limited Launches New Investor Relations WebsiteJune 18, 2026 5:00 PM
PR Newswire (US) MACAU, class="legendSpanClass"June 18, 2026 /PRNewswire/ -- Epsium Enterprise Limited (NASDAQ: EPSM) (the "Company") today announced the laun

Mesa Royalty Trust Announces There Will Be No Distribution for June 2026June 18, 2026 5:08 PM
Business WireMesa Royalty Trust (the “Trust”) (NYSE: MTR) announced today that there will be no distribution paid for the month of June 2026, as costs, charges and expenses attributabl

You say the CEO sold all of his shares. Why say something so blatantly false?

Provide a link for that?

Another paid basher. Hold on tight - I guess that means it's about to run up again.

back in full size .25's, will just add more lower

Let the Rat fly!

And now also on 2. 👋

The offerings always a possible

Here is what the analysis of investor losses says "22. In sum, using the methodology discussed above with bluesheet data to determine potential investor loss in NTGL during the period of December 11, 2015 through August 31, 2016, there were 123 accounts with overall losses. These customer accounts r